Evidence-Based Use of Indomethacin and Ibuprofen in the Neonatal Intensive Care Unit

• Autores: Palmer G. Johnston, Maria Gillam-Krakauer, M. Paige Fuller, Jeff Reese
• Localización: Clinics in Perinatology, ISSN 0095-5108, Vol. 39, Nº. 1, 2012, págs. 111-136
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • Indomethacin and ibuprofen are potent inhibitors of prostaglandin synthesis. Neonates have been exposed to these compounds for more than 3 decades. Indomethacin is commonly used to prevent intraventricular hemorrhage (IVH), and both drugs are prescribed for the treatment or prevention of patent ductus arteriosus (PDA). This review examines the basis for indomethacin and ibuprofen use in the neonatal intensive care population. Despite the call for restrained use of each drug, the most immature infants are likely to need pharmacologic approaches to reduce high-grade IVH, avoid the need for PDA ligation, and preserve the opportunity for an optimal outcome.